WASHINGTON, DC – Nearly two months ago, the House acted and passed H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, by an overwhelmingly bipartisan vote of 396-14. At the time, NBC News called it “…the most ambitious congressional push yet to address the growing opioid […]

The post NBC News on H.R. 6: “…the most ambitious congressional push yet…” appeared first on Energy and Commerce Committee.

WASHINGTON, DC – Earlier this year, members of the House Energy and Commerce Committee spotlighted legislation to help combat the opioid crisis. The series explained just a handful of the 57 legislative solutions that the committee advanced earlier this year. Today we revisit Rep. Tim Walberg’s (R-MI) video discussing H.R. 5009, Jessie’s Law, a bipartisan […]

The post Combating the Opioid Crisis: Walberg Spotlights Jessie’s Law appeared first on Energy and Commerce Committee.

WASHINGTON, DC – Health Subcommittee Vice Chairman Brett Guthrie (R-KY) recently penned an op-ed highlighting the House’s most recent efforts to combat the opioid crisis. By passing H.R. 6, the SUPPORT for Patients and Communities Act, the House acted once again to advance treatment and recovery initiatives, improve prevention, protect our communities, and bolster our efforts […]

The post ICYMI: Guthrie Op-Ed Highlights Recent Efforts to Combat the Opioid Crisis appeared first on Energy and Commerce Committee.

WASHINGTON – House Energy and Commerce Committee Chairman Greg Walden (R-OR) and Senate Finance Committee Chairman Orrin Hatch (R-UT) today urged Office of Management and Budget (OMB) Director Mick Mulvaney to consider the full economic effects of a proposed Health and Human Services (HHS)/Office of Inspector General rule that would alter the use of rebates […]

The post Walden and Hatch Call on OMB to Consider Economic Consequences of Proposed Drug Rebate Rule appeared first on Energy and Commerce Committee.

Excerpt: “While the details of the proposed rule are unavailable during the period of review, the publicly available title of the rule indicates that the action contemplated could be significant in scope, with the potential to dramatically change the process by which prescription drugs are purchased within the supply chain. Depending on the nature of […]

The post Letter to OMB Director Mick Mulvaney Regarding PBM Safe Harbor Rule appeared first on Energy and Commerce Committee.

WASHINGTON, DC – Earlier this year, members of the House Energy and Commerce Committee spotlighted legislation to help combat the opioid crisis. The series explained just a handful of the 57 legislative solutions that the committee advanced earlier this year. Today we revisit Rep. Mimi Walters’ (R-CA) video discussing H.R. 4684, the Ensuring Access to […]

The post Combating the Opioid Crisis: Walters Examines Treatment and Recovery Homes appeared first on Energy and Commerce Committee.

WASHINGTON, DC – Almost exactly one year ago, President Trump signed into law H.R. 2430, the FDA Reauthorization Act (FDARA). This important, bipartisan legislation reauthorized the Food and Drug Administration’s (FDA’s) critical medical product user fee programs, ensuring the agency has the tools it needs to more efficiently deliver safe and effective drugs, devices, and […]

The post FDARA is Boosting Generic Drug Competition appeared first on Energy and Commerce Committee.

WASHINGTON, DC – Energy and Commerce Committee Chairman Greg Walden (R-OR) held a roundtable in his district yesterday to discuss the opioid crisis and current efforts to combat it. Joining the chairman was Food and Drug Administration (FDA) Commissioner, Dr. Scott Gottlieb. Chairman Walden highlighted the House’s recent passage of H.R. 6, critical legislation to […]

The post Walden Holds Roundtable on Opioid Crisis with FDA Commissioner Gottlieb appeared first on Energy and Commerce Committee.